Evaluation of alcaftadine 0.25% ophthalmic solution in acute allergic conjunctivitis at 15 minutes and 16 hours after instillation versus placebo and olopatadine 0.1%

PURPOSE: To evaluate the effectiveness of alcaftadine 0.05%, 0.1%, and 0.25% ophthalmic solutions in treating the signs and symptoms of allergic conjunctivitis when compared with olopatadine hydrochloride 0.1% and placebo using the conjunctival allergen challenge (CAC) model. METHODS: One hundred an...

Descripción completa

Detalles Bibliográficos
Autores principales: Greiner, Jack V, Edwards-Swanson, Kimberly, Ingerman, Avner
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037035/
https://www.ncbi.nlm.nih.gov/pubmed/21339800
http://dx.doi.org/10.2147/OPTH.S15379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037035/
https://www.ncbi.nlm.nih.gov/pubmed/21339800
http://dx.doi.org/10.2147/OPTH.S15379

Ejemplares similares